Skip to content
Screener

Standard BioTools Inc. LAB Q1 2026 earnings

Reported May 5, 2026 · After market close

Revenue$21.1MBeat by $3.3M
EPS-$0.02In line
Revenue estimate$17.8M
EPS estimate-$0.02

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$18.8M
EPS estimate-$0.02

FAQ

When did Standard BioTools Inc. report Q1 2026 earnings?
Standard BioTools Inc. (LAB) reported Q1 2026 earnings on May 5, 2026 after market close.
What were Standard BioTools Inc.'s Q1 2026 revenue and EPS?
Standard BioTools Inc. reported revenue of $21.1M and eps of $-0.02 for Q1 2026.
Did Standard BioTools Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $17.8M by $3.3M. EPS beat the consensus estimate of $-0.02 by $0.00.
How did Standard BioTools Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 48.2% from $40.8M a year earlier and eps grew 50.0% from $-0.04.
Where can I find Standard BioTools Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-206395) and the 10-Q periodic report (0001193125-26-208967) directly on SEC EDGAR. The filing index links above go to sec.gov.